Immunotherapy for Advanced Cancer

active
URL
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.7643.2.1047
Version
20190108
PublisherOncology Nursing Society StewardDate2019-01-08T01:00:08-05:00Purpose

(Clinical Focus: This value set contains RxNORM codes associated with immunotherapy agents commonly used to treat patients with advanced stages of cancer.),(Data Element Scope: This would use the Medication QDM category.),(Inclusion Criteria: The following generic, prescribable immunotherapy agents are included in this value set: abemaciclib, afatinib, alectinib, alemtuzumab, atezolizumab, avelumab, axicabtagene ciloleucel, axitinib, bevacizumab, blinatumomab, bortezomib, brentuximab vedotin, brigatinib, cabozantinib, carfilzomib, ceritinib, cetuximab, cobimetinib, copanlisib, crizotinib, dabrafenib, daratumumab, dasatinib, dinutuximab, durvalumab, elotuzumab, erlotinib, everolimus, gefitinib, gemtuzumab ozogamicin, ibritumomab tiuxetan/yttrium-90, idelalisib, imatinib, inotuzumab ozogamicin, ipilimumab, ibrutinib, ixazomib, lapatinib, lenvatinib, midostaurin, neratinib, nilotinib, niraparib, nivolumab, obinutuzumab, ofatumumab, olaratumab, osimertinib, palbociclib, panitumumab, pazopanib, pembrolizumab, pertuzumab, ramucirumab, regorafenib, ribociclib, rituximab, romidepsin, rucaparib, siltuximab, sonidegib, sorafenib, sunitinib, temsirolimus, tisagenlecleucel, tositumomab, trametinib, trastuzumab, vandetanib, vemurafenib, vorinostat, vismodegib),(Exclusion Criteria: Immunotherapy agents not listed above are excluded from this value set, including brand name drugs or brand name drug packs.)

Expansion
<<>>>
CodeDisplaySystem
1594658http://www.nlm.nih.gov/research/umls/rxnorm
977438http://www.nlm.nih.gov/research/umls/rxnorm
845515http://www.nlm.nih.gov/research/umls/rxnorm
1987402http://www.nlm.nih.gov/research/umls/rxnorm
1873983http://www.nlm.nih.gov/research/umls/rxnorm
1430451http://www.nlm.nih.gov/research/umls/rxnorm
1721951http://www.nlm.nih.gov/research/umls/rxnorm
977434http://www.nlm.nih.gov/research/umls/rxnorm
643107http://www.nlm.nih.gov/research/umls/rxnorm
1726439http://www.nlm.nih.gov/research/umls/rxnorm
402243http://www.nlm.nih.gov/research/umls/rxnorm
403879http://www.nlm.nih.gov/research/umls/rxnorm
1927893http://www.nlm.nih.gov/research/umls/rxnorm
603208http://www.nlm.nih.gov/research/umls/rxnorm
1872478http://www.nlm.nih.gov/research/umls/rxnorm
349472http://www.nlm.nih.gov/research/umls/rxnorm
2000021http://www.nlm.nih.gov/research/umls/rxnorm
1424918http://www.nlm.nih.gov/research/umls/rxnorm
1657658http://www.nlm.nih.gov/research/umls/rxnorm
1604394http://www.nlm.nih.gov/research/umls/rxnorm